| Name | WAP four-disulfide core domain 21, pseudogene |
| Description | Predicted to enable enzyme activator activity. Predicted to act upstream of or within response to lipopolysaccharide; response to tumor necrosis factor; and white fat cell differentiation. Predicted to be located in extracellular space. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nIn hepatocellular carcinoma, WFDC21P acts as a tumor suppressor that is directly induced by the orphan nuclear receptor Nur77. Nur77 binds to response elements on the WFDC21P promoter to activate its transcription, and the resulting WFDC21P protein inhibits tumor growth and metastasis by interfering with glycolytic remodeling. Specifically, WFDC21P interacts with two key glycolytic enzymes—PFKP and PKM2—disrupting the formation of the active PFKP tetramer and preventing PKM2’s nuclear translocation, thereby suppressing glycolysis and its oncogenic consequences. This mechanism also underlies the therapeutic effects observed with Cytosporone-B, a Nur77 agonist, which works in a WFDC21P‐dependent manner."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn contrast, within lung carcinoma, WFDC21P appears to function as an oncogene. Here, enhanced expression of microRNA-4293 suppresses the mRNA decapping enzyme DCP2—a negative regulator of WFDC21P—resulting in elevated levels of WFDC21P. The increased expression of WFDC21P correlates with enhanced tumor cell proliferation and metastasis, and its knockdown attenuates the tumor-promoting effects of miR-4293, underscoring its direct contribution to lung cancer pathogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn gastric cancer, WFDC21P is significantly upregulated and its increased expression is associated with advanced disease stages. Functionally, WFDC21P promotes cellular proliferation and metastasis by directly binding to the GTPase Ran, which in turn enhances the activity of the Akt/GSK3β/β‐catenin signaling pathway. Furthermore, the transcription factor FOXP3 binds to the promoter region of WFDC21P to positively regulate its transcription, suggesting that WFDC21P may serve as both a novel biomarker and a potential therapeutic target in gastric cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yun-Feng Guan, Qiao-Ling Huang, Yuan-Li Ai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-020-1158-y"}], "href": "https://doi.org/10.1038/s41388-020-1158-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31959898"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31959898"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Qian Zhang, Yun-Fei Yan, Qing Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-4293 upregulates lncRNA WFDC21P by suppressing mRNA-decapping enzyme 2 to promote lung carcinoma proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-04021-y"}], "href": "https://doi.org/10.1038/s41419-021-04021-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34301920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34301920"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Huaiping Cui, Zhaoyu Jiang, Shujie Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A new candidate oncogenic lncRNA derived from pseudogene WFDC21P promotes tumor progression in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-04200-x"}], "href": "https://doi.org/10.1038/s41419-021-04200-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34601496"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34601496"}]}]}]}
|
| Synonyms | LNCDC, LINC-DC, LNC-DC |
| NCBI Gene ID | 645638 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
WFDC21P has 409 functional associations with biological entities spanning 3 categories (functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 11 datasets.
Click the + buttons to view associations for WFDC21P from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of WFDC21P gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of WFDC21P gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of WFDC21P gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with WFDC21P gene from the CellMarker Gene-Cell Type Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with WFDC21P gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of WFDC21P gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of WFDC21P gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with WFDC21P gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of WFDC21P gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of WFDC21P gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain WFDC21P protein from the LOCATE Predicted Protein Localization Annotations dataset. | |